Yes, the Morningstar SP valuation is a joke on FPH. It is embarrassing that they went from $11 to $16.4. What systematic risk review are they talking about? Clearly just made something up to save face. FPH has always been a low risk business.
Their $11 valuation was too low. They failed to update it for a year. It should have been changed to $12 based just on the growth rate of around 10% in NPAT over the year and probably more from a falling NZD/USD.
Safe to say that the SP has significant support around 15.00 NZD and will only go below this on negative news from the company (re-opening of cases with Resmed for example (very unlikely)) or a broad market sell-off like we had in December 2018.
- Forums
- ASX - By Stock
- FPH
- Ann: Fisher & Paykel Healthcare Reports Record Full Year Result
Ann: Fisher & Paykel Healthcare Reports Record Full Year Result, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FPH (ASX) to my watchlist
|
|||||
Last
$28.82 |
Change
-0.090(0.31%) |
Mkt cap ! $16.83B |
Open | High | Low | Value | Volume |
$28.70 | $28.85 | $28.32 | $35.46M | 1.238M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 10792 | $28.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.83 | 2342 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17930 | 28.700 |
1 | 3330 | 28.580 |
1 | 720 | 28.560 |
1 | 648 | 28.540 |
1 | 500 | 28.350 |
Price($) | Vol. | No. |
---|---|---|
28.830 | 793 | 2 |
28.840 | 3397 | 1 |
28.870 | 3397 | 1 |
28.900 | 3397 | 1 |
28.920 | 343 | 2 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
FPH (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online